Hailin Chen

Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma

Liang Lin, Shih‐Feng Cho, Lijie Xing et al. · Leukemia · 2020 · 85 citations · Full text

Hematological Malignancy, Cancer Immunosurveillance, Preclinical Evaluation +13

γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation

Hailin Chen, Tengteng Yu, Liang Lin et al. · Blood Cancer Journal · 2022 · 48 citations · Full text

VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo

Tengteng Yu, Bharat K. R. Chaganty, Liang Lin et al. · Blood Cancer Journal · 2020 · 42 citations · Full text

(−)-Meptazinol–melatonin hybrids as novel dual inhibitors of cholinesterases and amyloid-β aggregation with high antioxidant potency for Alzheimer’s therapy

Shaobing Cheng, Wei Zheng, Ping Gong et al. · Bioorganic & Medicinal Chemistry · 2015 · 26 citations

Neurodegenerative Diseases, Alzheimer's Disease, -Meptazinol–melatonin Hybrids +9

BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression

Lijie Xing, Su Wang, Jiye Liu et al. · Clinical Cancer Research · 2021 · 26 citations · Full text